Assessment of tumor suppressor promoter methylation in healthy individuals.
Deepak B PoduvalElisabet OgnedalZuzana SichmanovaEivind ValenGjertrud T IversenLaura MinsaasPer E LønningStian KnappskogPublished in: Clinical epigenetics (2020)
Methylation-specific NGS of our tumor suppressor panel, with detailed assessment of differential methylation in healthy individuals, presents a feasible method for identification of novel epigenetic risk factors for cancer.